http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-8200692-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e5edd48190cba3fa70dd3975efd9831
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-47
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 1981-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1981-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-8200692-A1
titleOfInvention PROCEDURE FOR THE PREPARATION OF NEW CEPHALOSPORINS
abstract PROCEDURE FOR PREPARING CEPHALOSPORINS OF FORMULA (I), WHERE A IS PHENYL 4-HYDROXYPHENYL, CYCLOHEXYL OR OTHERS; D HYDROGEN, HYDROXY, ACETOXY AND OTHERS; R HYDROGEN, METHYL, CYCLOPROPYL OR OTHERS, AND E HYDROGEN OR AN EASILY REMOVABLE PROTECTING GROUP "IN VITRO". A COMPOUND D FORMULA (II) IS REACTED AT A TEMPERATURE OF -120 TO -10 C WITH AN ALKALI METAL METHYLATE, IN THE PRESENCE OF EXCESS METHANOL, AND IN AN INERT SOLVENT MEDIUM. THE REACTION MIXTURE IS TREATED WITH A HALOHENATION AGENT, SUCH AS HALOGENS, N-HALOGENOIMIDES, ETC. ONCE THE REACTION IS COMPLETED, THE EXCESS HALOGENATION AGENT IS REMOVED BY MEANS OF A REDUCING AGENT. OF APPLICATION AS ANTIBIOTICS AGENTS
priorityDate 1979-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457637794
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148241513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457637874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17852246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410441661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410436561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457798372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457798390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457803324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457801358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397132

Total number of triples: 43.